Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) Director Nancy A. Simonian sold 134,713 shares of the company’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $0.27, for a total value of $36,372.51. Following the transaction, the director now directly owns 41,070 shares in the company, […]

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) EVP Tolga Tanguler sold 1,469 shares of Alnylam Pharmaceuticals stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $250.98, for a total value of $368,689.62. Following the transaction, the executive vice president now owns 13,191 shares in the company, […]

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) General Counsel Martin Wilson sold 1,175 shares of Rocket Pharmaceuticals stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $13.05, for a total transaction of $15,333.75. Following the completion of the transaction, the general counsel now directly owns 63,560 […]

Dai ichi Life Insurance Company Ltd reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 16.1% in the third quarter, according to its most recent filing with the SEC. The fund owned 12,392 shares of the biopharmaceutical company’s stock after selling 2,383 shares during the quarter. Dai ichi Life Insurance […]